Stay updated with breaking news from Program Modifications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA approved a modification to the Mifepristone Risk Evaluation and Mitigation Strategy, REMS, Program. The FDA’s approval of commercial dispensing of mifepristone likely will not change the current practice of prescribing and dispensing mifepristone for abortion.
The number and cost of federal regulations increased substantially in 2015, as regulators continued to tighten restrictions on American businesses and individuals. The addition of 43 new major rules last year increased annual regulatory costs by more than $22 billion, bringing the total annual costs of Obama Administration rules to an astonishing $100 billon-plus in just seven years.
Congressman Jim Himes Provides Federal COVID Relief Bill Update Written by Wilton First Selectwoman, Lynne Vanderslice Congressman Jim Himes' Office provided the First Selectwoman's Office with the following summary of programs for businesses and individuals contained in the current bi-partisan COVID-19 relief bill. You can also watch Congressman Himes' discussion of the bill at this morning's meeting with members of the Western Connecticut Council of Governments on this link. Small Business Support Small biz w/ less than 10 employees: $15B reserved for loans made by small...